Page 517 of 863: studies 5,161 to 5,170 of 8,627, newest first. Back to the addiction overview
Libro Comunicaciones 2021
La ayahuasca1 es una decocción tradicional amazónica con propiedades psicoactivas, se elabora a partir de la corteza de la vid Banisteriopsis caapi (que contiene alcaloides betacarbolina) y las hojas del arbusto Psychotria viridis (que suministra el alucinógeno N, N-dimetiltriptamina, DMT, que actúa como agonista serotoninérgico 5-HT2A). La ayahuasca se ha incorporado a la medicina popular y la...
Journal of Behavioral and Brain Science 2021 Shannon O’brien, David M. Compton, Julianna M. Davis et al.
Traditionally, ketamine was considered useful as a dissociative anesthetic. More recently, ketamine has been examined for its effects as a fast-acting antidepressant, for treatment-resistant depression, and as a non-opiate treatment of chronic pain. Unfortunately, ketamine has enjoyed popularity as a recreational drug among both adolescents and young adults. While some research suggests the use...
Libro Comunicaciones 2021
- Objetivos: Ayahuasca es una bebida compuesta por Banisteriopsis caapi, rica en β-carbolinas (harmina, tetrahidroharmina y harmalina) y Psychotria viridis, rica en dimetiltriptamina (DMT). β-carbolinas funcionan como inhibidores reversibles de la enzima monoaminooxidasa A, involucrada en la inhibición del metabolismo de DMT. DMT es un agonista parcial de los receptores de serotonina con...
FOCUS: The Journal of Lifelong Learning in Psychiatry 2021 Collin Reiff, Elon E. Richman, Charles B. Nemeroff et al. 17 citations
Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders. Methods: Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on “psilocybin,” “lysergic acid diethylamide,” “LSD,” “ayahuasca,” “3,4-methylenedioxymethamphetamine,” and “MDMA,” in...
Mendelova univerzita v Brně eBooks 2021 Tereza Rumlerová, Olivia Marcus, Jesús M. González Mariscal et al. 2 citations
Sanz-Biset & Cañigueral, 2011), son aún escasas las publicaciones al respecto.El dispositivo de la dieta está compuesto por una serie de estrictas normas, que implican el aislamiento, pautas rigurosas de alimentación y cuidados de la actividad sexual.No se puede tomar alcohol ni tener relaciones sexuales (incluida la masturbación), además de numerosas restricciones alimenticias entre las que se...
Dissent 2021 Sophie Pinkham 1 citation
The Problem of Pain Sophie Pinkham (bio) White Market Drugs: Big Pharma and the Hidden History of Addiction in America by David Herzberg University of Chicago Press, 2020, 400 pp. Click for larger view View full resolution A worker removes the Sackler name from a building at Tufts University in 2019. (David L. Ryan/The Boston Globe via Getty Images) [End Page 130] Reams have been written about...
Brazilian Journal of Development 2021 Vagner Fagnani Linartevichi, Matheus Gonzales Froza, Rafael de Morais Cury et al. 4 citations
A depressão, ou Distúrbio Depressivo Maior (DDM), é uma enfermidade que acomete cerca de 322 milhões de pessoas e pode ser debilitante, havendo uma grande demanda para tratamentos eficazes no manejo desta doença. O presente estudo teve por objetivo organizar uma revisão de artigos publicados acerca do uso do composto psilocibina, a fim de averiguar seu potencial terapêutico no tratamento de...
Bioengineered 2021 William E. Gibbons, Madeline G. Mckinney, Philip J. O’dell et al. 8 citations
Psilocybin, a drug most commonly recognized as a recreational psychedelic, is quickly gaining attention as a promising therapy for an expanding range of neurological conditions, including depression, anxiety, and addiction. This growing interest has led to many recent advancements in psilocybin synthesis strategies, including multiple in vivo fermentation-based approaches catalyzed by...
Porto Biomedical Journal 2021 Henrique Castro Santos, João Gama Marques 37 citations
Abstract Background: Psilocybin is a predominant agonist of 5HT 1A and 5HT 2A/C receptors and was first isolated in 1958, shortly before it became a controlled substance. Research on the potential therapeutic effects of this compound has recently re-emerged alongside what is being addressed as a psychedelic renaissance. Methods: In this paper we performed a systematic review of the clinical...
Frontiers in Pharmacology 2021 Johannes T. Reckweg, Natasha L. Mason, Cees van Leeuwen et al. 58 citations
5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a tryptamine with ultra-rapid onset and short duration of psychedelic effects. Prospective studies for other tryptamines have suggested beneficial effects on mental health outcomes. In preparation for a study in patients with depression, the present study GH001-HV-101 aimed to assess the impact of four different dose levels of a novel vaporized...